Landscapes / Companies

Cogent Biosciences, Inc. not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Phase 3
Next date
CGT4859, Phase 1/2 trial completes
Drugs
4
in active trials · 5 in all
Trials
6 active
8 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
Tyrosine kinase inhibitor
Phase 3 —
—
Phase 1/2 Mar 2027Phase 1/2 trial completes
—
Phase 1 May 2028Phase 1 trial completes
—
Phase 1 Jul 2029Phase 1 trial completes

About

No active trial
ACTR707
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Cogent Biosciences, Inc.

Following is part of Solo: you see every change to Cogent Biosciences, Inc. the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in